Advertisement
Screener

GALECTIN THERAPEUTICS INC. (GALT) Shares Authorized

2.8 / 5 stars · 68/120 Roast Me

GALECTIN THERAPEUTICS INC. Shares Authorized

GALECTIN THERAPEUTICS INC. (GALT) had Shares Authorized of 150.00 million shares as of 2026-06-30, per its 10-Q filed 2026-08-14.

Financial Statements › Balance Sheet › Equity › Stockholders' Equity, Number of Shares, Par Value and Other Disclosure › Common Stock, Number of Shares, Par Value and Other Disclosure

us-gaap:CommonStockSharesAuthorized · last filed 2026-08-14

  • 2026-06-30: Common Stock, Shares Authorized 150.00M shares.
  • 2026-03-31: Common Stock, Shares Authorized 150.00M shares.
  • 2025-12-31: Common Stock, Shares Authorized 150.00M shares.
  • 2025-09-30: Common Stock, Shares Authorized 150.00M shares.
Period endCommon Stock, Shares AuthorizedCommon Stock, Shares Authorized as first filed
2026-06-30150.00M shares
10-Q · filed 2026-08-14
2026-03-31150.00M shares
10-Q · filed 2026-05-15
2025-12-31150.00M shares
10-Q · filed 2026-08-14
2025-09-30150.00M shares
10-Q · filed 2025-11-14
2025-06-30150.00M shares
10-Q · filed 2025-08-14
2025-03-31150.00M shares
10-Q · filed 2025-05-15
2024-12-31150.00M shares
10-K · filed 2026-03-31
2024-09-30150.00M shares
10-Q · filed 2024-11-14
2024-06-30150.00M shares
10-Q · filed 2024-08-13
2024-03-31150.00M shares
10-Q · filed 2024-05-15
2023-12-31150.00M shares
10-K · filed 2025-03-31
2023-09-30150.00M shares
10-Q · filed 2023-11-13
2023-06-30150.00M shares
10-Q · filed 2023-08-14
2023-03-31150.00M shares
10-Q · filed 2023-05-15
2022-12-31150.00M shares
10-K · filed 2024-03-29
2022-09-30150.00M shares
10-Q · filed 2022-11-14
2022-06-30150.00M shares
10-Q · filed 2022-08-15
2022-03-31150.00M shares
10-Q · filed 2022-05-16
2021-12-31150.00M shares
10-K · filed 2023-03-30
2021-09-30100.00M shares
10-Q · filed 2021-11-15
2021-06-30100.00M shares
10-Q · filed 2021-08-16
2021-03-31100.00M shares
10-Q · filed 2021-05-17
2020-12-31100.00M shares
10-K · filed 2022-03-31
2020-09-30100.00M shares
10-Q · filed 2020-11-09
2020-06-30100.00M shares
10-Q · filed 2020-08-10
2020-03-31100.00M shares
10-Q · filed 2020-05-11
2019-12-31100.00M shares
10-K · filed 2021-03-31
2019-09-30100.00M shares
10-Q · filed 2019-11-12
2019-06-30100.00M shares
10-Q · filed 2019-08-09
2019-03-31100.00M shares
10-Q · filed 2019-05-10
2018-12-31100.00M shares
10-K · filed 2020-03-16
2018-09-30100.00M shares
10-Q · filed 2018-11-13
2018-06-30100.00M shares
10-Q · filed 2018-08-14
2018-03-3150.00M shares
10-Q · filed 2018-05-11
2017-12-3150.00M shares
10-K · filed 2019-03-06
2017-09-3050.00M shares
10-Q · filed 2017-11-07
2017-06-3050.00M shares
10-Q · filed 2017-08-14
2017-03-3150.00M shares
10-Q · filed 2017-05-15
2016-12-3150.00M shares
10-K · filed 2018-03-29
2016-09-3050.00M shares
10-Q · filed 2016-11-08
2016-06-3050.00M shares
10-Q · filed 2016-08-09
2016-03-3150.00M shares
10-Q · filed 2016-05-10
2015-12-3150.00M shares
10-K · filed 2017-03-28
2015-09-3050.00M shares
10-Q · filed 2015-11-09
2015-06-3050.00M shares
10-Q · filed 2015-08-10
2015-03-3150.00M shares
10-Q · filed 2015-05-11
2014-12-3150.00M shares
10-K · filed 2016-03-15
2014-09-3050.00M shares
10-Q · filed 2014-11-10
2014-06-3050.00M shares
10-Q · filed 2014-08-07
2014-03-3150.00M shares
10-Q · filed 2014-05-13
2013-12-3150.00M shares
10-K · filed 2015-03-18
2013-09-3050.00M shares
10-Q · filed 2013-11-12
2013-06-3050.00M shares
10-Q · filed 2013-08-14
2013-03-3150.00M shares
10-Q · filed 2013-05-10
2012-12-3150.00M shares
10-K · filed 2014-03-21
2012-09-3050.00M shares
10-Q · filed 2012-11-09
2012-06-3050.00M shares
10-Q · filed 2012-08-10
2012-03-3150.00M shares
10-Q · filed 2012-05-11
2011-12-3150.00M shares
10-K · filed 2013-03-29
2011-09-30300.00M shares
10-Q · filed 2011-11-10
2011-06-30300.00M shares
10-Q · filed 2011-08-12
2010-12-3150.00M shares
10-K · filed 2012-03-30
300.00M shares
10-Q · filed 2011-08-12

Similar stocks

Stock NameCountryMarket CapPE Ratio
Arcturus Therapeutics Holdings Inc. (ARCT)$0.402B-2.05
Turn Therapeutics Inc. (TTRX)United States$0.397B-25.68
Opus Genetics, Inc. (IRD)United States$0.406B-3.16
RELMADA THERAPEUTICS, INC. (RLMD)United States$0.406B-11.92
ARS Pharmaceuticals, Inc. (SPRY)United States$0.414B-3.70
Atea Pharmaceuticals, Inc. (AVIR)United States$0.414B-2.26
Rezolute, Inc. (RZLT)United States$0.382B-6.45
DiaMedica Therapeutics Inc. (DMAC)United States$0.423B-10.11
PROTHENA CORP PUBLIC LTD CO (PRTA)Ireland$0.428B-11.53
CYPHERPUNK TECHNOLOGIES INC. (CYPH)United States$0.438B-75.63